iCPS Breast Cancer Europe · Thursday, 23rd May 2019 10:00 am to 3:45 pm Hotel Pullman Brussels Centre Midi #iCPSroundtables iCPS Breast Cancer Europe Roundtable 2019 Healthcare_Breast

Thursday, 23rd May 201910:00 am to 3:45 pm Hotel Pullman Brussels Centre Midi

#iCPSroundtables

iCPS Breast Cancer EuropeRoundtable 2019

Healthcare_Breast Cancer Roundtable Brochure 2019_v1.indd 1 20/05/2019 16:19:07


On behalf of the International Centre for Parliamentary Studies, I would like to welcome you to the iCPS Breast Cancer Europe Roundtable, here in Brussels, the heart of policy in the European Union.

I would like to express my gratitude to the European Commission, European Parliament, Europa Donna and other key stakeholders within the European breast cancer community for attending today.

Over the years iCPS has endeavored to provide a platform for policy makers, national representatives, patient groups, academic experts, practitioners, patient groups and industry from across the European Union to come together to discuss the key challenges and opportunities in the field of healthcare. We actively promote and encourage a multi-stakeholder inclusive set of recommendations on improving the health of patients suffering from Europe’s most prevalent diseases, such as cancer, diabetes, cardiovascular and metabolic diseases, infectious diseases and mental disorders.

Today, we come together to evaluate the progress made toward conquering breast cancer in Europe and examine current policy guidelines and strategies to support member states in managing and caring for EU citizens with this devastating disease.

According to GLOBOCAN 2018, breast cancer was by far the most common cancer among women in 2018 (24%), with 2.1 million people diagnosed and no fewer than 627,000 deaths worldwide, of which 98,755 in Europe. It is the cancer that causes the most deaths in absolute terms. Breast cancer incidence rates are highest in the so-called developed regions (Australia, New Zealand, Europe and North America), with the world record being held by Belgium with 188 cases per 100,000 women.

Despite significant advancements in treatment pathways, there are clear inequalities in access to rapid diagnosis and treatments across Europe. While there are several good breast cancer services across the continent, wide variations in healthcare systems have resulted in inequalities in multidisciplinary care. Metastasis, the leading cause of breast cancer deaths killd nearly half a million people per year across the world. To reverse this trend, it is pertinent to tackle the persisting gaps and missed opportunities in the EU battle against breast cancer. The basis for such an action lies in an objective and factual assessment of the situation.

During the roundtable, we will examine the ongoing challenges in managing breast cancer more effectively and explore practical solutions in order to reach an EU-wide consensus and implement a forward action plan.

We encourage you to join in and participate during the discussions in order to ‘stress test’ suggestions and solutions. Notes will also be taken today and form part of an Overview, featuring within a Breast Cancer Report which will be published in the Government Gazette, the quarterly European policy publication.

At the end of the roundtable, you will be invited to share your recommendations by submitting a contribution within the Breast Cancer Report, details of which are on page 9. The report will act as the formal platform to communicate our recommendations. It will be delivered to European and member state policy makers within healthcare and specifically those with a vested interest in improving cancer care.

Finally, I would like to thank Professor Robert Mansel who will chair this significant roundtable and help maximize the collective expertise here.

I hope you have a productive day and enjoy our networking lunch this afternoon.

Join the conversation on Twitter @GovtGazette

Sincerely,Alexander SmithHead of European Healthcare, iCPS


International Centre for Parliamentary Studies (iCPS)…………..........................…………......….......

Chair and Presenters’ Biographies......…………………………….........................……………............

Programme………………………………………………………............................………..................

List of Participants...…………………………………………............................……………...............

Seating Plan…………………………………………………............................................................…

Breast Cancer Report..........…………........................……...............................................................……

iCPS Staff Contact Details……………………………..................................….................…….…..…

Pages

1

2-3

4

5-7

8

9

10

Contents


The International Centre for Parliamentary Studies (iCPS) exists to promote effective policy making and good governance through better interaction between Parliaments, Governments and other stakeholders in society.

The Centre’s primary focus is the empowerment of human capital through capacity building. To this effect, the Centre organises a range of training programmes, conferences, policy discussions and research projects to address current public policy issues in the United Kingdom, the European Union and on the international stage. These provide a forum for policy discussion, debate, networking and sharing of best practices.

iCPS publishes the Government Gazette, a quarterly publication that brings a unique and rounded perspective to the major issues of the day affecting good governance. Written for and read by eminent parliamentarians, academics and policy experts, Government Gazette is predominantly read by an elite circle of policymakers across Europe.

The Centre also offers international consultancy services across a range of areas, including electoral affairs, regulation, governance, public sector reform, health and security.

It operates from its head office in United Kingdom and has regional offices in Belgium, United States and Mauritius. It has a large team of public policy researchers, training experts and internationally renowned speakers.

The International Centre for Parliamentary Studies

Past Speakers & Contributors

1

John DalliFormer European Commissioner for Health and Consumer Policy

Magdy Martínez-SolimánAssistant Secretary-General, United Nations

Viviane RedingFormer Vice-president for Justice, Fundamental rights and Citizenship

Vytenis AndriukaitisEuropean Commissioner for Health and Food Safety

Cecilia Malmstrom David Cameron Helle Thorning-SchmidtGunther Oettinger

Alojz Peterle MEPPresident, MEPs Against Cancer, European Parliament

Lieve Wierinck MEPMember of the European Parliament

Miriam Dalli MEPMember of the European Parliament

Karin Kadenbach MEPMember of the European Parliament

Former European Commissioner for Digital Economy & Society

Former UK Prime Minister Former Danish Prime MinisterEuropean Commissioner for Trade


Chair and Presenter’s Biography

2

Prof. Robert Mansel CBEEmeritus Professor of Surgery, Cardiff University School of Medicine, UKChair of the iCPS Breast Cancer Europe Roundtable 2019

Professor Robert Mansel is currently Emeritus Professor of Surgery in Cardiff University School of Medicine.

His recent research interests have focused on benign breast disease, sentinel node biopsy trials in breast cancer, tamoxifen prevention therapy and genetic services for high-risk breast cancer families. He is joint author of a textbook of benign breast disease (3rd Edn, 2009). He is a PI in the IBIS and AMAROS trials.

Professor Mansel’s profound commitment to breast cancer research has led to his keen involvement with numerous societies, groups and committees dedicated to advancing scientific understanding and increasing public awareness of the disease. He has served as President of BASO and the Association of Breast Surgeons in the past, and is the immediate past President of the European Society of Mastology (EUSOMA). He is the Chair of the European Commission’s Quality Assurance Group (QASDG), which is writing the template for the accreditation of breast units throughout Europe.

He is a member of the ECCO Oncopolicy Committee, and was the President of the recent European Breast Cancer Conference (EBCC-11) in March 2018 in Barcelona.

Lieve Wierinck MEPMember MAC Group, European Parliament

Lieve Wierinck is a Flemish politician for the liberal Open VLD party. Mrs. Wierinck holds a pharmaceutical degree from the VUB (Vrije Universiteit Brussel). In addition, she obtained a Post-graduate degree of Pharmaceutical management in 2006 at the University of Hasselt. In line with her academic background, she owned and managed a pharmacy for nearly 30 years.

Before joining the European Parliament, Lieve was leader of the party fraction in Zaventem, followed by her twelve-year presidency of the OCMW (Public Centre for Social Welfare), where she managed a staff of a 150 people. She combined this with her obligations as a fulltime member of the City Council of Zaventem. From December 2011 until June 2014, she was a member of the Belgian Federal Parliament, where she was a member of the Committee for Public Health, Environment and Social Renewal, and of the Advisory Committee on Societal Emancipation.

In May 2016, Lieve replaced Mr De Backer as a Member of the European Parliament, where she is a full member of the Industry, Technology, Research and Energy Committee (ITRE) and a substitute Member of the Committee on Economic and Monetary affairs (ECON).


3

Presenters’ Biographies

Dr. Luciana Neamtiu Project Officer, European Initiative on Breast Cancer (ECICC), JRC – European Commission

Dr. Luciana Neamtiu graduated in Mathematics and Physics and obtained a PhD in Mathematics focusing on mathematics and computer science applied to medicine. She worked for fifteen years in the area of cancer registries and screening databases and collaborated to the setting-up of the population based cervical cancer screening programme and the regional cancer registry in Romania.

Now she is a member of the Health in Society Unit at Joint Research Centre’s European Commission and she works for the European Cancer Information System (ECIS), the European Commission Initiative on Breast Cancer (ECIBC) and the European Commission Initiative on Colorectal Cancer (ECICC).

The aim of the ECIBC is to improve quality of care by developing evidence-based breast cancer guidelines and supporting their implementation via a quality assurance scheme for breast cancer services.

Mona Knotek-RoggenbauerPresident Europa Donna

Mona Knotek-Roggenbauer is currently the President of Europa Donna – The European Breast Cancer Coalition.

After surviving from breast Cancer, sepsis and a multi-organ failure in 2011, Ms. Knotek-Roggenbauer has served as Vice President of Europa Donna and a member of the executive board for several years. She also served as the President of the Europa Donna Austria in 2014, where she started her volunteering.

Prior to her work at Europa Donna and its member organisations, she worked within the pharmaceutical industry. She has worked with several industry leaders including Novartis Oncology, Schering Plough, Organon and Kwizda.

She has authored several key publications including Zigeunerschnitzel? Geht nicht! - Diversity aus Sicht von Personalverantwortlichen, Du bist nicht allein – Diagnose Brustkrebs: Leitfaden für Betroffene, and You are Not Alone – Diagnosis Breast Cancer: Guide for Patients.


4

Programme

Chair: Prof. Robert Mansel CBE, Emeritus Professor of Surgery, Cardiff University School of Medicine, UK

09:30 – 10:00 Registration and Morning Coffee

10:00 – 11:30 Session I: Analysing the Current Policy Framework of Non-metastatic and Metastatic Breast Cancer in the EU and Member States

• Welcome address by Alexander Smith, Head of European Healthcare, iCPS • Opening of Roundtable by Prof. Robert Mansel CBE, Chair • Viewpoint by Dr. Luciana Neamtiu, Project Officer, European Initiative on Breast Cancer (ECICC), JRC – European Commission) • Viewpoint by Lieve Wierinck MEP, Member MAC Group, European Parliament • Viewpoint by Mona Knotek-Roggenbauer, President Europa Donna - The European Breast Cancer Coalition • Improving EU-wide collaboration between cancer registries, training and disseminating information on incidence and mortality: What steps need to be taken? • Pan-European equity in cancer treatment: where are we?

11:30 – 11:45 Group Photo and Coffee Break

11:45 – 13:00 Session II: Improving Diagnosis and Patient Treatment

• Early detection & accurate screening and rapid diagnosis practices • Best practices: Overcoming participation barriers in breast cancer screening • Novel strategies on Personalized Medicines for treatment and patient care and biobank involvement • Therapy options; the role of immunotherapy, chemotherapy, surgery, hormone therapy and radiotherapy • How can we ensure the provision of a consistent treatment strategy across a multi-disciplinary team (MDT)? • Updates from Clinical Trials: Katherine Phase III, TAM-01 Phase III and GEICAM/CIBOMA Phase III

13:00 – 14:00 Networking Lunch

14:00 – 15:15 Session III: Fostering Research, Innovation and Drugs Development

• Metastatic Breast Cancer: Highlights and breakthroughs of 2018 • Triple negative breast cancers (TNBCs): Clinical Trials & design of improved therapeutic strategies • Development of next-generation chemotherapeutic agents • How can we ensure flexibility in regulatory pathways and sustainable funding mechanisms to encourage R&D? • BRCA gene-mutant breast cancers: new therapeutics and approved treatments

15:15 – 15:45 Recommendations and Close of Roundtable

• Recommendations for policy makers, governments and key stakeholders to support an EU-wide strategy : tour de table of each participant’s final recommendation for the Breast Cancer Report • Chair’s closing remarks


List of Participants

No. Organisation Name Job Title Country

1 Agendia Prof. Laura van 't Veer Chief Research Officer The Netherlands

2 AZ Sint-Jan Dr. Ivo Vanden Berghe MD Belgium

3 Azienda Socio - Sanitaria Territoriale di Cremon a Prof. Daniele Generali Director Italy

4 Breast Unit and Prevention Centre Isala Dr. Birgit Carly Head Breast Clinic, CHU St

Pierre Belgium

5Brustkrebs Deutschland e.V. (German Breast Cancer Association)

Renate Haidinger President Germany

6 Cardiff University School of Medicine Prof. Robert Mansel CBE Emeritus Professor of Surgery United

Kingdom

7 Daiichi Sankyo Europe Dr. Markus Lucerna Medical Director Germany

8 Eurocarers Claire Champeix Policy Officer Belgium

9 Europa Donna Mona Knotek-Roggenbauer President Austria

10 Europa Donna Croatia Dr. Vesna Ramljak MD PhD Croatia

11 European Cancer Organisation Pascale Blaes EU Affairs Policy Manager Belgium

5




12 European Cancer Patient Coalition Isabelle Manneh Head of Health and Research

Programmes Belgium

13 European Commission Dr. Luciana Neamtiu PhD, Project Officer, Healthcare Quality Team Italy

14 European Parliament Lieve Wierinck MEP Member, MEPs Against Cancer Group Belgium

15 European Society of Surgical Oncology (ESSO) Prof. Lynda Wyld Co-lead of the BRESO (Breast

Surgical Oncology Project) Belgium

16 GE Healthcare Nicola Maidwell Northern Europe Marketing Leader

United Kingdom

17 GE Healthcare Alexandra Schulz Commercial & Marketing Manager ABUS Germany

18 Hologic Dr. Christian Stoeckigt Head of Scientific Affairs Germany

19 Hôpital Saint Louis Dr. Luis Teixeira Associate Professor, M.D, Ph.D France

20 Institute of Oncology Ljubljana Dr. Simona Borstnar Medical Oncologist Slovenia

21 Istituto Oncologico Veneto Prof. Pierfranco Conte Professor Italy

22 Karolinska University Hospital Prof. Kerstin Sandelin Professor Sweden

6



23 Liga Portuguesa Contra o Cancro Vitor Rodrigues President, LPCC Portugal

24 Liga Portuguesa Contra o Cancro Dr. Isilda Pegado Representative, Europa Donna Portugal

25 Marienhospital Bottrop GmbH Dr. Hans-Christian Kolberg Head of Department OB/GYN Germany

26 Oxford University Hospitals NHSFT Pankaj G Roy Consultant Oncoplastic Breast

SurgeonUnited Kingdom

27Riga Eastern University Hospital Oncology Center of Latvia, University of Latvia

Prof. Alinta Hegmane Medical oncologist; ECIBC National Contact for Latvia Latvia

28 Technical University of Munich Dr. Stephan Metz Senior Physician Breast

Imaging Germany

29The Oncology Institute "Prof. Dr. Ion chiricuta" Cluj-Napoca

Dr. Florian Alexandru Nicula Screening Manager Romania

30 University of Antwerp Prof. Didier Verhoeven Medical Oncologist Belgium

31 University of Perugia Prof. Antonio RulliDirector Breast Unit, Director of General and Oncological Surgery Section

Italy


7


8

Seating Plan

Alexander Smith, iCPS

Dr. Luciana Neamtiu, European

Commission

Mona Knotek-Roggenbauer,EuropaDonna

Lieve Wierinck

MEP

Prof. RobertMansel

CBE, Chair

Pascale Blaes, European Cancer

Organisation

Alexandra Schulz, GE Healthcare

Dr. Birgit Carly, Breast Unit and Prevention Centre Isala

Prof. Lynda Wyld, European Society of Surgical Oncology

Prof. Laura van ‘t Veer, Agendia

Isabelle Manneh, European Cancer Patient Coalition

Dr. Florian Alexandru Nicula,

The Oncology Institute “Prof. Dr.

Ion chiricuta” Cluj-Napoca

Nicola Maidwell, GE Healthcare

Prof. Alinta Hegmane,

Riga Eastern University Hospital

Oncology Center of

Latvia, University of

Latvia

Dr. Christian Stoeckigt, Hologic

Dr. Markus Lucerna, Daiichi Sankyo Europe

Dr. Stephan Metz,

Technical University of Munich

Pankaj G Roy, Oxford University Hospitals

NHSFT

Prof. Antonio Rulli,

University of Perugia

Prof. Didier Verhoeven, University

of Antwerp

Claire Champeix, Eurocarers

Vesna Ramljak, Europa Donna Croatia

Renate Haidinger, German Breast Cancer Association

Dr. Luis Teixeira, Hôpital Saint Louis

Prof. Pierfranco Conte, Istituto Oncologico Veneto

Vitor Rodrigues, Liga Portuguesa Contra o Cancro

Dr. Hans-Christian Kolberg, Marienhospital Bottrop GmbH

Dr. Ivo Vanden Berghe, AZ Sint-Jan

Prof. Daniele Generali, Azienda Socio - Sanitaria Territoriale di Cremon a

Dr. Simona Borstnar, Institute of Oncology Ljubljana

Prof. Kerstin Sandelin, Karolinska University Hospital

Dr. Isilda Pegado, Liga Portuguesa Contra o Cancro


As the official media partner of the Breast Cancer Europe Roundtable, Government Gazette will publish a Breast CanCer report in January 2020. It will analyse current policy guidelines and strategies promoting the effective prevention and treatment of breast cancer in Europe. The Report will include perspectives from health professionals, industry leaders and academics. Key challenges will be highlighted and recommendations will be included to support policy making.

As a participant of the Roundtable, we invite you to contribute within the Breast CanCer report. This can include your viewpoints or recommendations regarding current policies on prevention, education, treatment, care or research relating to breast cancer within Europe. The precise focus of the contribution could be on any aspect of breast cancer you may currently wish to focus or draw attention to.

Please send your contributions to [email protected] by Friday, July 5, 2019 with a maximum word count of 800 words. Please be advised that your contribution will be published in the print, online and digital editions of Government Gazette.

Government Gazette provides politically neutral and objective coverage of all leading institutions and policy makers in the European Union. The standard of excellence has made it a place where parliamentarians, policy shapers and eminent thought leaders turn to express their views within their extended policy circles. The magazine enables informed policy making by encouraging an open debate on a range of timely policy issues, triggering active participation from policy shapers, activists and lobbyists; and creating readily-usable content for discerning decision-makers.

Government Gazette has a strong print readership of over 7,500 within the European Union. The Breast CanCer report is targeted at our influential readership that includes all MEPs, senior members of the EU Commission, senior officials in the European Council, all senior executives within European Medicines Agency, senior executives at European Health Product Agencies, all European Healthcare Payers, HTAs, National Cancer Boards, Health Ministers and Medical Officers of the 28 EU Member States. The Report is also read by senior decision makers and academics in major healthcare research institutions, medical societies, patient groups and businesses across Europe. The Report is also read by medical societies, patient groups, senior decision makers and academics in major healthcare research institutions and businesses across Europe.

We look forward to receiving your contribution.

Janani Krishnaswamy Commissioning Editor, Government Gazette

9

Breast CanCer reportRecommendations to reshape policy making

Dr. Christian Stoeckigt, Hologic


iCPS Staff Contact Details

Alexander SmithHead of European Healthcare

[email protected]

Zahia Guidoum CastiblanqueResearch and Production Manager

[email protected]

Janani KrishnaswamyCommissioning Editor, Government Gazette

[email protected]


Previous Participating Organisations



Documents

iCPS Breast Cancer Europe · Thursday, 23rd May 2019 10:00 am to 3:45 pm Hotel Pullman Brussels Centre Midi #iCPSroundtables iCPS Breast Cancer Europe Roundtable 2019 Healthcare_Breast